ACADIA PHARMACEUTICALS INC (ACAD) › Net IncomeACADIA PHARMACEUTICALS INC (ACAD) — Net IncomeAnnual figures by fiscal year, from SEC filings.2009: -$45.15M2010: $15.14M2011: -$22.77M2012: -$20.85M2013: -$37.95M2014: -$92.47M2015: -$164.44M2016: -$271.39M2017: -$289.40M2018: -$245.19M2019: -$235.26M2020: -$281.58M2021: -$167.87M2022: -$215.97M2023: -$61.29M2024: $226.45M2025: $391.00M$391.00M2009Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025$391.00M+72.7%2024$226.45M+469.5%2023-$61.29M+71.6%2022-$215.97M-28.7%2021-$167.87M+40.4%2020-$281.58M-19.7%2019-$235.26M+4.1%2018-$245.19M+15.3%2017-$289.40M-6.6%2016-$271.39M-65.0%2015-$164.44M-77.8%2014-$92.47M-143.7%2013-$37.95M-82.0%2012-$20.85M+8.4%2011-$22.77M-250.4%2010$15.14M+133.5%2009-$45.15M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share